COMMUNIQUÉS West-GlobeNewswire

PROCEPT BioRobotics® to Attend Four Upcoming Investor Conferences in May & June
29/04/2025
SAN JOSE, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, [...]
BridgeBio Reports First Quarter 2025 Financial Results and Business Updates
29/04/2025
- $36.7 million in first full quarter of U.S. Attruby™ net product revenue and as of April 25, 2025, 2,072 unique patient prescriptions written by 756 unique prescribers - Observational run-in study for [...]
BeautyHealth to Report First Quarter 2025 Financial Results on May 8, 2025
29/04/2025
LONG BEACH, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announced it will report first quarter 2025 financial results after market close [...]
Artios Pharma Reports Differentiated Clinical Activity in STELLA Phase 1/2a Study for Lead Program ART0380 at the American Association for Cancer Research (AACR) Annual Meeting 2025
29/04/2025
ART0380 in combination with low-dose irinotecan demonstrated a 50% confirmed overall response rate (cORR) in patients with Ataxia-Telangiectasia Mutated (ATM)-negative 1 solid tumors at the recommended Phase 2 dose ( [...]
Nouscom Presents Positive Final Results from Completed Phase Ib/II Study of Neoantigen Immunotherapy NOUS-209 at AACR 2025, Demonstrating a Highly Potent and Durable Immune Response in Lynch Syndrome Carriers
29/04/2025
Lynch Syndrome (LS) is a common hereditary condition that significantly increases the lifetime risk of cancer, especially colorectal and endometrial, to as high as 80% NOUS-209 is an off-the-shelf immunotherapy designed [...]
GENFIT Announces Publication of the 2024 Universal Registration Document and the 2024 Annual Report on Form 20-F
29/04/2025
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), April 29, 2025 - GENFIT (Nasdaq and Euronext: GNFT) , a biopharmaceutical company dedicated to improving the lives of patients with rare [...]
GENFIT : Mise à disposition du Document d’Enregistrement Universel 2024 et du Rapport Annuel Form 20-F 2024
29/04/2025
Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 29 avril 2025 – GENFIT (Nasdaq et Euronext: GNFT) , société biopharmaceutique engagée dans l’amélioration de la vie des patients atteints de [...]
Eurobio Scientific: MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2024
29/04/2025
MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2024 Paris, le 29 avril 2025 Eurobio Scientific (FR0013240934, ALERS, éligible PEA-PME), groupe français leader dans le diagnostic médical in vitro de spécialité, annonce [...]
Mitolyn Reviews Consumer Reports 2025 - Mitolyn Reviews And Complaints - Mitolyn Weight Loss Supplement - What Is Mitolyn - Does Mitolyn Work - Is Mitolyn Legit or Scam!
29/04/2025
Tallmadge, OH, April 29, 2025 (GLOBE NEWSWIRE) -- (When people look for weight loss supplements, their experiences and real results matter more than advertisements. Mitolyn is gaining attention, and many are asking: [...]
Best Steroid for Women for Muscle Growth and Fat Loss 2025 - Top Anabolic Steroids for Female Bodybuilders With Before and After Results - CrazyBulk
29/04/2025
New York City, April 29, 2025 (GLOBE NEWSWIRE) -- Best steroids for women for building muscle and losing fat presented by CrazyBulk Are you a female bodybuilder or athlete looking to take your physique to the next level [...]
Tevogen Informs Public Shareholders About DRS Accounts And Differences to Brokerage Accounts
29/04/2025
WARREN, N.J., April 29, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), today informed shareholders about several differences between holding shares in Direct Registration [...]
NADP Advocates for Greater Access to Care through Dental Coverage
29/04/2025
Association Represents Dental Benefits Industry at Advocacy in Action DALLAS, April 29, 2025 (GLOBE NEWSWIRE) -- The National Association of Dental Plans (NADP) demonstrated its strong commitment to expanding access to [...]
Louw Alberts Psychology Practice Rebrands from Talk It Out to Strengthen Identity
29/04/2025
Embracing a New Identity: Louw Alberts Psychology Practice Centurion, Gauteng, April 29, 2025 (GLOBE NEWSWIRE) -- Louw Alberts Psychology Practice, a renowned counselling practice based in Centurion, South Africa, has [...]
PLANT ADVANCED TECHONOLIGES (PAT) : Résultats Annuels 2024
29/04/2025
Vandœuvre-lès-Nancy, le 29 avril 2025 – 18 : 00 (CET) Communiqué de presse Pour diffusion immédiate Résultats Annuels 2024 de la Société PAT Premier résultat d'exploitation positif depuis la création de PAT en 2005 : [...]
EssilorLuxottica: Disclosure of transactions in own shares
29/04/2025
Disclosure of transactions in own shares Paris, France (April 29, 2025 - 6:00 pm) – In accordance with the authorization granted by the Annual Shareholders’ Meeting on April 30, 2024, EssilorLuxottica declares that from [...]
EssilorLuxottica: Déclaration de transactions sur actions propres
29/04/2025
Déclaration de transactions sur actions propres Paris, France (29 avril 2025, 18h00) – Conformément à l’autorisation octroyée par l’Assemblée Générale du 30 avril 2024, EssilorLuxottica déclare que du 22 avril 2025 au [...]
Lirum Therapeutics’ LX-101 New Positive Data Selected for Presentation at the 2025 American Association for Cancer Research (AACR) Annual Meeting
29/04/2025
New York, NY, April 29, 2025 (GLOBE NEWSWIRE) -- Lirum Therapeutics, Inc. (“Lirum”), an innovative clinical-stage biopharmaceutical company focused on the treatment of debilitating diseases, announced today that new [...]
Combined General Meeting of May 21, 2025 - Availability of preparatory documents
29/04/2025
Press Release Paris – April 29, 2025 – EUROAPI’s shareholders are invited to attend the Combined General Meeting to be held on Wednesday May 21, 2025 at 10:30 a.m. (CET) at 15 bis, rue Traversière 75012 Paris. The [...]
Assemblée Générale mixte du 21 mai 2025 - Modalités de mise à disposition ou de consultation des documents préparatoires
29/04/2025
Communiqué de presse Paris – Le 29 avril 2025 – Les actionnaires d’EUROAPI sont invités à participer à l’Assemblée Générale mixte qui se tiendra le mercredi 21 mai 2025 à 10h30 au 15 bis rue Traversière 75012 Paris. L’ [...]

Pages